Impact Biomedical Inc.
IBO- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001834105
In the last 90 days, Impact Biomedical Inc. insiders filed 0 open-market purchases and 1 sale; 23 institutions reported holding it in 13F filings for Q2 2026, worth $1.76M in total; no superinvestor holds it.
Holders of 5% or more of IBO
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Impact Biomedical Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Impact Biomedical Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on Impact Biomedical Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Apr 4, 20255:15 PM ET | Chan Heng Fai Ambroseand 3 others | 13D/A | 2.90%351.6K shares | −14.00 ppfrom 16.90%Below 5% | Apr 2, 2025 | SEC |
| Apr 2, 20259:55 PM ET | Chan Heng Fai Ambroseand 3 others | 13D | 16.90%2.04M shares | New | Mar 31, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Impact Biomedical Inc. shares.
No Form 144 notices for Impact Biomedical Inc. are on file.